Biomarkers of cardiovascular disease: molecular basis and practical considerations.
about
Genome-wide association with select biomarker traits in the Framingham Heart StudyEffect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analysesPrognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology studyCancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposureProspective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular diseaseRisk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgmentUtility of mass spectrometry for the diagnosis of the unstable coronary plaqueGenetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunctionThe role of natriuretic peptides for the diagnosis of left ventricular dysfunctionEffects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsIdentifying novel biomarkers for cardiovascular disease risk predictionDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsProteomics and metabolomics in renal transplantation-quo vadis?The integrated effect of moderate exercise on coronary heart diseaseBiomarkers in heart failure: the importance of inconvenient detailsBiomarkers of lung injury in cardiothoracic surgery3-nitrotyrosine modified proteins in atherosclerosisTop-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failureReview and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanismsDo non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strainsTransient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse modelNovel biomarkers for risk stratification in pulmonary arterial hypertensionCardiovascular genomics: a biomarker identification pipelineCocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trialRole of circulating factors in cardiac aging.Microfluidic blood cell sorting: now and beyond.The potential value of integrated natriuretic peptide and echo-guided heart failure management.Integration of biosensors and drug delivery technologies for early detection and chronic management of illnessEmerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical TrialsIndividual assessment of arteriosclerosis by empiric clinical profilingPlasma biomarkers for prediction of sudden cardiac death: another piece of the risk stratification puzzle?Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach.Red blood cell fatty acid patterns and acute coronary syndrome.Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.Cardiovascular proteomics: implications for clinical applicationsBiomarkers in acute myocardial infarction.
P2860
Q21261433-60803B46-5E10-426C-AD80-0E9C34ED4266Q22306540-27A17A3F-D497-4D95-A5A7-59AC6E450FC1Q24289043-9E98991B-C9C7-4BFB-922B-5E0C60C975D8Q24614387-4530D477-C4A0-4E88-B759-533E761981DDQ26739721-C42763C7-450D-4B94-9DE2-1DD4E84DB0E2Q26769732-DE8D76E1-2CB9-4F4A-96B9-311840CDD6FAQ26780282-80555207-23D3-426D-941D-6907E4BB320DQ26824460-3D493133-3D41-447E-9B74-14F099C4DF91Q26825665-DB82D65D-160E-4F9E-B338-FF0D69DC4B9DQ26827245-6EA55B38-FAA4-4190-B6B0-7CA8DC5C6AE5Q26865722-F55F9724-A5A2-4B31-919B-099BF6FADAE4Q26996955-C3B6E5BF-D594-462C-80E9-765432F6932EQ27024418-D5EB3DD9-8BF5-421B-96A0-8FC20F756881Q28066764-06D56325-273C-44E4-B2BF-0F3DB0A4E3A6Q28067646-89434BCE-91DF-4485-BF61-D82072B4FF81Q28080960-DF7302F5-2763-4F83-874E-B01667F91726Q28083260-A768D296-0B44-4039-99D7-14EF0D2F3285Q28243166-99BB4590-B591-45BA-BB2D-3F2425D24223Q28387812-A0B5947C-2F15-44A4-9F96-29AF4B48517AQ28387928-3EA6CDBE-6D9F-40C2-AA29-6113303200A9Q28394187-F349F6DA-229E-496D-9A85-FF9C129D0E6EQ28540580-729B6A99-D7A2-4477-A6CF-FDE9BC65349DQ28596829-0BF3BB0D-DB57-4B26-B5CF-E7A68F7EED6EQ28596902-DE1181D0-265B-4AB3-A658-D46F5FAEABA8Q28731712-BAEAE8E1-B98E-4196-A2CA-69542A8C90A0Q30234641-164C6D34-0502-49D5-A7ED-AE08C8DD2EBEQ30412049-451A248E-E616-4DD9-8C37-0079D878F6E4Q30434020-6B14BF94-758D-44CD-ADF6-8424D252E976Q30451853-F384C1C4-32D1-44B3-BC9F-7CD5B4EABA7FQ30475719-B6C08283-8207-4BCE-9190-EAA6C280E4B2Q31142754-7333734E-7F13-4DC1-B580-45BAEEC0E4C0Q33307524-25368D48-BAF5-46AC-A557-0334E59CACB7Q33353044-7CF4666A-AEFE-4C35-866F-4D6CF0346191Q33377856-6F5A811E-B85C-4D57-8006-A2928E93C32CQ33394532-AA2AA80B-E9EF-4E4B-B63B-5723B10E316EQ33440563-C1078B0D-78D6-4D8A-A453-6927AC4CEB9AQ33552596-2452C9B4-0B36-4A08-A9C2-D8BD81AB21A5Q33552642-38621B44-D181-463B-ABD4-75AE18FD1536Q33579184-C36C4863-5F1F-4C77-9EEB-15F8626FAAA8Q33596823-7A16032E-DA45-4878-B146-450B9640BBFE
P2860
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@ast
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@en
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@nl
type
label
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@ast
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@en
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@nl
prefLabel
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@ast
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@en
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@nl
P1433
P1476
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
@en
P304
P356
10.1161/CIRCULATIONAHA.104.482570
P407
P577
2006-05-01T00:00:00Z